New research shows that Rytvela, an anti-inflammatory drug candidate, decreased premature birth and infant mortality when ...
Please provide your email address to receive an email when new articles are posted on . There is no neonatal benefit or harm when using tocolytic drugs for threatened premature birth after 30 weeks’ ...
Despite advancements in the medical field, more than half a million babies are born too soon in the United States. According to the March of Dimes, this country's premature birth rate has risen by 36 ...
In honor of Women’s Health Month, reproductive health researcher and Assistant Professor Scott Barnett from the Department of Biochemistry & Molecular Biology shares the sobering reality of the rising ...
The new compound called Rytvela prevents preterm birth and organ damage in animal studies by stopping inflammation, whereas the common drug nifedipine failed.
Mary J. Scourboutakos does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...
February 17, 2011 (UPDATED February 27, 2011)— Clinicians should not use injectable terbutaline to prevent preterm labor or treat it beyond 48 to 72 hours because of the risk for maternal heart ...
April 23 (Reuters) - Novartis (NOVN.S), opens new tab has been hit with a lawsuit by people with autism and their mothers alleging the drugmaker illegally promoted an asthma drug for treatment of ...
Elizabeth Campbell holds her daughter, who was born 6 weeks premature, before participating in the March for Babies at Old Fairgrounds Park in Valparaiso this past April. The March of Dimes and health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results